Results 101 to 110 of about 3,869 (134)
Some of the next articles are maybe not open access.

Immune T cells controlTrypanosoma cruzi infections

Experientia, 1981
Immune but not normal T cells were able fully to restore the ability of thymectomized, irradiated, fetal liver reconstituted ‘B’ mice to controlTrypanosoma cruzi infections.
A C, Corsini, A, Stelini
openaire   +2 more sources

Molecular Characterization and Diagnosis of Trypanosoma cruzi and T. rangeli

Archives of Medical Research, 2002
The parasitic protozoan Trypanosoma cruzi infects an estimated 16 million individuals in Latin America. In a variable proportion of patients, this infection can result in a life-threatening cardiac or digestive pathology recognized as Chagas disease.
Felipe, Guhl   +3 more
openaire   +2 more sources

Trypanosoma lewisi, T. acomys and T. cruzi: A method for their cultivation with mammalian tissue

Experimental Parasitology, 1977
Abstract Trypanosoma lewisi, T. acomys, and T. cruzi were grown in vitro at 37 C in culture media with mammalian cells. The trypanosomes and the host tissues cultured readily from infected animals (Lewis rats, mice, and Acomys cahirinus). The majority of T. lewisi grown at 37 C were trypomastigotes. Cultures of T.
J, El-On, C L, Greenblatt
openaire   +2 more sources

Epitopes common to trypanosomes (T. cruzi, T. dionisii and T. vespertilionis (Schizotrypanum)): astrocytes and neurons

Journal of Neuroimmunology, 1987
An autoimmune mechanism is commonly invoked to explain the occurrence of neuronal destruction in the chronic phase of Chagas' disease. Monoclonal antibodies raised against T. dionisii (DION) and T. vespertilionis (VESP), and cross-reactive with T. cruzi recognize antigens in cultured cerebellar cells from embryonic and postnatal mice, as revealed by ...
K, Petry   +3 more
openaire   +2 more sources

Role of ROS in T. cruzi Intracellular Development

2019
Chagas disease, caused by the protozoan Trypanosoma cruzi, presents a variable clinical course ranging from asymptomatic cases to more severe forms with cardiac, digestive, or cardio-digestive impairment. The factors involved in this clinical heterogeneity are not completely understood, but certainly both host and parasite genetic variability are ...
Luciana O. Andrade   +1 more
openaire   +1 more source

[Agglutination reaction of T. cruzi, T. cruzi like Strains, T. rangeli and T. conorhini with Soja hispida lectin and Aaptos papillata protectin (author's transl)].

Tropenmedizin und Parasitologie, 1977
Protectin from the sponge Aaptos papillata (Keller) was used in the characterization of five strains of T. cruzi (Venezuela, Guatemala, Y. Brasilien, Peru, Wien) and six T. cruzi like strains (Triatoma, Maryland, ITMAP 943, FH4, FH5, LN). Based upon their membrane receptors, these T. cruzi and T. cruzi like isolates could be differentiated from rangeli
H, Mühlpfordt, J, Schottelius
openaire   +1 more source

Transfer of immunity to T. Cruzi

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1974
Edward L. Roberson, William L. Hanson
openaire   +1 more source

Basic Biology of Trypanosoma cruzi

Current Pharmaceutical Design, 2021
Wanderley De Souza
exaly  

[Differentiation by microimmunofluorescence of T. cruzi and T. cruzi-like strains from T. conorhini and T. rangeli, using protection from the sponge Aaptos papillata (author's transl)].

Zeitschrift fur Parasitenkunde (Berlin, Germany), 1979
Carbohydrates containing terminal nonreducting D N-acetylgalactosamin or D N-acetylglucosamin were identified at the cell surface of Trypanosoma cruzi by an indirect immunofluorescence test using the lectin of the sponge Aaptos papillata. With the method described in this study T. cruzi and T. cruzi-like strains are easy to distinguish from T. rangeli,
H, Bretting, J, Schottelius
openaire   +1 more source

Antitumor Mechanisms of Molecules Secreted by Trypanosoma cruzi in Colon and Breast Cancer: A Review

Anti-Cancer Agents in Medicinal Chemistry, 2023
Hassan Borji   +2 more
exaly  

Home - About - Disclaimer - Privacy